vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company whose core business model relies on animal testing for drug development. The company’s pipeline of oral small molecule drug candidates, including treatments for diabetes and Alzheimer’s disease, requires preclinical testing on animals as a standard regulatory step. This activity constitutes commercial exploitation of animals for product development.

Cruelty Free Investors, a leading exclusionary screening resource, lists vTv Therapeutics on its “Companies That Exploit Animals” database under the category of animal testing for 2022, 2023, and 2024. The company’s SEC filings and scientific publications reference animal experiments conducted in accordance with U.S. regulatory standards, confirming that animal use is an integral part of its research and development process. As a company whose primary activity is developing pharmaceutical candidates, vTv Therapeutics’ operations are fundamentally dependent on animal testing.